Results 361 to 370 of about 17,182,321 (391)

Complete Response in Hairy Cell Leukemia to Anti-CD22 CAR T-Cell Therapy. [PDF]

JCO Precis Oncol
Kreitman RJ, Schroeder B, Arons E, Yuan C, Wang HW, Raffeld M, Xi L, Pittaluga S, Zhou H, Gould M, Shpilman I, Turkbey E, Calvo KR, James L, Ortiz OS, Highfill S, Stroncek D, Yates B, Pastan I, Shah NN.   +19 more
europepmc   +1 more source

Cardiovascular toxicities associated with chimeric antigen receptor T-cell therapy. [PDF]

Front Pharmacol
Liu JH, Liu KY, Zhao X, Zhou X, Jiang Y.
europepmc   +1 more source

Regulatory T cell therapy for Graft-versus-Host Disease. [PDF]

Bone Marrow Transplant
Lysandrou M, Kefala D, Vinnakota JM, Savvopoulos N, Zeiser R, Spyridonidis A.   +5 more
europepmc   +1 more source

CAR-NK cell therapy: promise and challenges in solid tumors. [PDF]

Front Immunol
Balkhi S, Zuccolotto G, Di Spirito A, Rosato A, Mortara L.   +4 more
europepmc   +1 more source

Neurological complications associated with chimeric antigen receptor T cell therapy. [PDF]

J Cereb Blood Flow Metab
Yan S, Zhou M, Zhu X, Xiao Y.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

T Cell Therapies

2007
T cell therapies are increasingly used for the treatment of malignancies and viral-associated diseases. Initial studies focused on the use of unmanipulated T cell populations after allogeneic stem cell transplantation. More recently, the use of antigen-specific T cells has been explored.
Barbara Savoldo, Gianpietro Dotti, Helen E. Heslop, Chrystal U. Louis, Malcolm K. Brenner, Stephen Gottschalk, C.M. Rooney, Karin Straathof, Catherine M. Bollard   +8 more
openaire   +3 more sources

T-cell therapies for T-cell lymphoma

Cytotherapy, 2019
T-cell lymphomas represent a subpopulation of non-Hodgkin lymphomas with poor outcomes when treated with conventional chemotherapy. A variety of novel agents have been introduced as new treatment strategies either as first-line treatment or in conjunction with chemotherapy. Immunotherapy has been demonstrated to be a promising area for new therapeutics,
Keri Toner, Catherine M. Bollard, Hema Dave   +2 more
openaire   +3 more sources

Cell therapy in the heart

Canadian Journal of Physiology and Pharmacology, 2012
Cell therapy is emerging as a new strategy to circumvent the adverse effects of heart disease. Many experimental and clinical studies investigating the transplantation of cells into the injured myocardium have yielded promising results. Moreover, data from these reports show that transplanted stem cells can engraft within the myocardium, differentiate
Abdelli, Latifa S., Merino, Hilda, Rocher, Crystal M., Singla, Dinender K.   +3 more
openaire   +4 more sources